Сноски
1
Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15–4927, NSDUH Series H 50). Retrieved from http://www.samhsa.gov/data/.
2
Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of twelve-month DSM — IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 2005 Jun; 62(6): 617–27.
3
Lenzenweger MF, Lane MC, Loranger AW, Kessler RC (2007). DSM — IV personality disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 62(6), 553–564.
4
Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The de facto mental and addictive disorders service system. Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services. Archives of General Psychiatry. 1993 Feb; 50(2): 85–94.
5
Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15–4927, NSDUH Series H 50). Retrieved from http://www.samhsa.gov/data/.
6
http://ria.ru/society/20141010/1027775155.html.
7
Kessler RC, Angermeyer M, Anthony Jc, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry. 2007; 6(3): 168–176.
8
http://gutta-honey.livejournal.com/113296.html
9
Marazziti D, Akiskal HS, Rossi A, Cassano GB. Alteration of the platelet serotonin transporter in romantic love. Psychol Med. 1999 May; 29(3): 741–5
10
Bentall RP. A proposal to classify happiness as a psychiatric disorder. Journal of Medical Ethics. 1992; 18(2): 94–98
11
https://www.youtube.com/watch?v=G_Qwp2GdB1M
12
Dima D, Roiser JP, Dietrich DE, Bonnemann C, Lanfermann H, Emrich HM, Dillo W. Understanding why patients with schizophrenia do not perceive the hollow-mask illusion using dynamic causal modelling. Neuroimage. 2009 Jul 15; 46(4): 1180–6. doi: 10.1016/j.neuroimage.2009.03.033. Epub 2009 Mar 24.
13
Rosenhan DL. On being sane in insane places. Science. 1973 Jan 19; 179(4070): 250–8.
14
Progler Y. Mental illness and social stigma: notes on «How Mad Are You?» Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences. 2009; 14(5): 331–334.
15
Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J Affect Disord. 2009. Se; 117(1–2): 1–17.
16
Contribution of depression to cognitive impairment and dementia in older adults. Neurologist. 2007 May; 13(3): 105–17.
17
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (Fifth ed.). Arlington, VA: American Psychiatric Publishing, p. 20. ISBN978–0–89042–555–8
18
Dalgleish T. The emotional brain. Nat Rev Neurosci. 2004 Jul; 5(7): 583–9. Review
19
Mega MS, Cummings JL, Salloway S, Malloy P. The limbic system: an anatomic, phylogenetic, and clinical perspective. J Neuropsychiatry Clin Neurosci. 1997 Summer; 9(3): 315–30. Review
20
Robert Sapolsky (2005). «Biology and Human Behavior: The Neurological Origins of Individuality, 2nd edition». The Teaching Company, p. 13 & 14 of Guide Book
21
de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Camí J. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit. 2004 Apr; 26(2): 137–44. Review
22
Hofmann A. (1983). LSD, my problem child: Reflections on sacred drugs, mysticism, and science. Los Angeles: J. P. Tarcher. P. 21
23
Andersson A, Wiréhn A-B, Ölvander C, Ekman DS, Bendtsen P. Alcohol use among university students in Sweden measured by an electronic screening instrument. BMC Public Health. 2009;9:229. doi: 10.1186/1471–2458–9–229
24
Nichols DE. Hallucinogens. Pharmacol Ther. 2004 Feb; 101(2): 131–81. Review.
25
Setola V, Hufeisen SJ, Grande-Allen KJ, Vesely I, Glennon RA, Blough B, Rothman RB, Roth BL. 3,4-methylenedioxymethamphetamine (MDMA, «Ecstasy») induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol Pharmacol. 2003 Jun; 63(6): 1223–9
26
Kennett GA, Ainsworth K, Trail B, Blackburn TP. BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacology. 1997 Feb; 36(2): 233–9
27
Rothman RB, Baumann MH, Savage JE, Rauser L, McBride A, Hufeisen SJ, Roth BL. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation. 2000 Dec 5; 102(23): 2836–41
28
Kellett J, Kokkinidis L. Extinction deficit and fear reinstatement after electrical stimulation of the amygdala: implications for kindling-associated fear and anxiety. Neuroscience. 2004; 127(2): 277–87
29
Ghaemi SN. The rise and fall of the biopsychosocial model. Br J Psychiatry. 2009 Jul; 195(1): 3–4. doi: 10.1192/bjp.bp.109.063859
30
Haygarth, John. (1800). Of the imagination, as a cause and as a cure of disorders of the body; exemplified by fictitious tractors, and epidemical convulsions. Read to the Literary and Philosophical Society of Bath. By John Haygarth, M.D. … Bath: printed by R. Cruttwell; and sold by Cadell and Davies, London
31
Beecher HK. The powerful placebo. J Am Med Assoc. 1955; 159(17): 1602–6
32
Howick J, Friedemann C, Tsakok M, et al. Are treatments more effective than placebos? A systematic review and meta-analysis. PLoS ONE. 2013; 8(5): e62599
33
Linde K, Fässler M, Meissner K. Placebo interventions, placebo effects and clinical practice. Philos Trans R Soc Lond, B, Biol Sci. 2011; 366(1572): 1905–12
34
Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry. 2008; 65(2): 220–31
35
Oken BS. Placebo effects: clinical aspects and neurobiology. Brain. 2008; 131(Pt 11): 2812–23.
36
Matre D, Casey KL, Knardahl S. Placebo-induced changes in spinal cord pain processing. J Neurosci. 2006; 26(2): 559–63
37
Qiu YH, Wu XY, Xu H, Sackett D. Neuroimaging study of placebo analgesia in humans. Neurosci Bull. 2009; 25(5): 277–82
38
Zubieta JK, Stohler CS. Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci. 2009; 1156: 198–210
39
Lidstone SC, Stoessl AJ. Understanding the placebo effect: contributions from neuroimaging. Mol Imaging Biol. 2007; 9(4): 176–85
40
Misra S. Randomized double blind placebo control studies, the «Gold Standard» in intervention based studies. Indian Journal of Sexually Transmitted Diseases. 2012; 33(2): 131–134
41
Levine R. A Real Mental Ward Becomes A Movie 'Cuckoo's Nest'. The New York Times. April 13, 1975. http://www.nytimes.com/packages/html/movies/bestpictures/cuckoo-ar1.html. Accessed Feb 25, 2016
42
Tooth GC, and Newton, MP: Leukotomy in England and Wales 1942–1954. London, Her Majesty's Stationary Office, 1961
43
Jansson B. Controversial Psychosurgery Resulted in a Nobel Prize. Nobel Media AB2014. http://www.nobelprize.org/nobel_prizes/medicine/laureates/1949/moniz-article.html. Accessed Feb 25, 2016
44
Soares MS, Paiva WS, Guertzenstein EZ, et al. Psychosurgery for schizophrenia: history and perspectives. Neuropsychiatric Disease and Treatment. 2013; 9: 509–515
45
http://www.youtube.com/watch?v=yQa_sg4zN88
46
Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003; 361(9360): 799–808
47
Fitzgerald PB. Non-pharmacological biological treatment approaches to difficult-to-treat depression. Med J Aust. 2013; 199(6 Suppl): 48–51
48
Task Force on Electroconvulsive Therapy. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging. 2nd ed. Washington, DC: American Psychiatric Publishing, 2001.
49
MacQueen G, Parkin C, Marriott M, Bégin H, Hasey G. The long-term impact of treatment with electroconvulsive therapy on discrete memory systems in patients with bipolar disorder. Journal of Psychiatry & Neuroscience. 2007; 32(4): 241–249
50
Coentre R, Barrocas D, Chendo I, et al. [Electroconvulsive therapy: myths and evidences]. Acta Med Port. 2009; 22(3): 275–80
51
Cristancho MA, Alici Y, Augoustides JG, O'reardon JP. Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician. Curr Psychiatry Rep. 2008; 10(6): 474–80
52
Wilkins KM, Ostroff R, Tampi RR. Efficacy of electroconvulsive therapy in the treatment of nondepressed psychiatric illness in elderly patients: a review of the literature. J Geriatr Psychiatry Neurol. 2008; 21(1): 3–11
53
Golenkov A, Ungvari GS, Gazdag G. Public attitudes towards electroconvulsive therapy in the Chuvash Republic. Int J Soc Psychiatry. 2012; 58(3): 289–94
54
Martin CD. Ernest Hemingway: a psychological autopsy of a suicide. Psychiatry. 2006; 69(4): 351–61
55
Swartz C. Electroconvulsive and Neuromodulation Therapies. Cambridge University Press; 2009. P. 185–187
56
Leopold T. (2016, November 18), Sam Phillips, Elvis and the invention of rock 'n' roll, CNN, Available at: http://edition.cnn.com/2015/11/18/entertainment/sam-phillips-sun-records-guralnick-feat/. Accessed February 24, 2016
57
Rawsthorn A. Yves Saint Laurent, a biography. Nan A. Talese; 1996
58
The Atlantic Monthly; January 1996; Bud's Bubble; Volume 277, No. 1; pages 99–102
59
Gardiner H. & Carey B., Researchers Fail to Reveal Full Drug Pay, The New York Times, Jun 8, 2008
60
Мартынихин И. О состоянии стационарных психиатрических учреждений РФ, Российское общество психиатров (6 декабря 2013 г., 09:35). http://psychiatr.ru/news/192
61
Reininghaus U, Priebe S, Bentall RP. Testing the Psychopathology of Psychosis: Evidence for a General Psychosis Dimension. Schizophrenia Bulletin. 2013; 39(4): 884–895
62
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013; 381(9875): 1371–9.
63
Maj M. «Psychiatric comorbidity»: an artefact of current diagnostic systems?. Br J Psychiatry. 2005;186: 182–4.
64
Подробнее о каждом из лекарств см. в соответствующих разделах.
65
Reininghaus U, Priebe S, Bentall RP. Testing the Psychopathology of Psychosis: Evidence for a General Psychosis Dimension. Schizophrenia Bulletin. 2013; 39(4): 884–895
66
Wampold BE, Minami T, Tierney SC, Baskin TW, Bhati KS. The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials. J Clin Psychol. 2005; 61(7): 835–54
67
World Health Organization. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization
68
Kessler RC, Aguilar-Gaxiola S, Alonso J, et al. The global burden of mental disorders: An update from the WHO World Mental Health (WMH) Surveys. Epidemiologia e psichiatria sociale. 2009; 18(1): 23–33.
69
Ciftci, Ayse, Nev Jones, and Patrick W. Corrigan. «Mental Health Stigma In The Muslim Community». Journal of Muslim Mental Health 7.1 (2013): n. pag. Web
70
Xu JM. Some issues in the diagnosis of depression in China. Can J Psychiatry. 1987; 32(5): 368–70
71
Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013; 10(11).
72
Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2013; 43(5): 897–910
73
Kessler RC, Aguilar-Gaxiola S, Alonso J, et al. The global burden of mental disorders: An update from the WHO World Mental Health (WMH) Surveys. Epidemiologia e psichiatria sociale. 2009; 18(1): 23–33
74
www.youtube.com/watch?v=NXB6slJSbL4
75
Saint Martin ML. Running Amok: A Modern Perspective on a Culture-Bound Syndrome. Primary Care Companion to The Journal of Clinical Psychiatry. 1999; 1(3): 66–70.
76
http://theoryandpractice.ru/posts/11759-sosland
77
Ablow K., We are raising a generation of deluded narcissists, Fox News, January 08, 2013.
78
Compton WM, Conway KP, Stinson FS, Grant BF. Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991–1992 and 2001–2002. Am J Psychiatry. 2006; 163(12): 2141–7.
79
Andrade L, Caraveo-anduaga JJ, Berglund P, et al. The epidemiology of m. Int J Methods Psychiatr Rajor depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. 2003; 12(1): 3–21
80
Twenge JM, Gentile B, Dewall CN, Ma D, Lacefield K, Schurtz DR. Birth cohort increases in psychopathology among young Americans, 1938–2007: A cross-temporal meta-analysis of the MMPI. Clin Psychol Rev. 2010; 30(2): 145–54
81
Hollan DW, Wellenkamp JC. Contentment and suffering: Culture and experience in Toraja. Columbia Univ Pr; 1994
82
Hidaka BH. Depression as a disease of modernity: explanations for increasing prevalence. Journal of Affective Disorders. 2012; 140(3): 205–214. doi: 10.1016/j.jad.2011.12.036
83
Hidaka BH. Depression as a disease of modernity: explanations for increasing prevalence. Journal of Affective Disorders. 2012; 140(3): 205–214. doi: 10.1016/j.jad.2011.12.036
84
Hidaka BH. Depression as a disease of modernity: explanations for increasing prevalence. Journal of Affective Disorders. 2012; 140(3): 205–214. doi: 10.1016/j.jad.2011.12.036
85
Hibbeln JR. Fish consumption and major depression. Lancet. 1998; 351(9110): 1213
86
Kitayama S, Markus HR, Matsumoto H, Norasakkunkit V. Individual and collective processes in the construction of the self: self-enhancement in the United States and self-criticism in Japan. J Pers Soc Psychol. 1997; 72(6): 1245–67
87
https://www.thelancet.com/commissions/global-mental-health
88
https://www.who.int/news-room/fact-sheets/detail/depression
89
DALY, disability-adjusted life year, — потенциальный год жизни, утраченный из-за преждевременной смерти, инвалидности или слабого здоровья, рассчитывается, как сумма двух слагаемых: YLL (Years Life Lost — потери, обусловленные смертностью) и YLD (Years Lost due to Disability — потери здоровья, обусловленные нетрудоспособностью). Global Health Estimates 2019: 20 Leading Causes of DALY globally, 2019 and 2000.
90
Merikangas KR, He J, Burstein M, et al. Lifetime Prevalence of Mental Disorders in US Adolescents: Results from the National Comorbidity Study-Adolescent Supplement (NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry. 2010; 49(10): 980–989. doi:10.1016/j.jaac.2010.05.017
91
Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: U. S. Department of Health and Human Services; 2014
92
Akinbami LJ, Moorman JE, Bailey C, et al. Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010. NCHS data brief, no 94. Hyattsville, MD: National Center for Health Statistics. 2012
93
Prevalence of mood disorders in the rural population of Udmurtia. Pakriev, Acta Psychiatr Scand. 1998 Mar; 97(3): 169–74
94
Simon GE, VonKorff M. Recognition, management, and outcomes of depression in primary care. Arch Fam Med 1995; 4: 99–105
95
МКБ-11.
96
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association, 1994
97
World Health Organization. The ICD-1 °Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization, 1992
98
Tsuang MT, Taylor L, Faraone SV. An overview of the genetics of psychotic mood disorders. J Psychiatr Res. 2004; 38: 3–15
99
Nutt DJ (2008). «Relationship of neurotransmitters to the symptoms of major depressive disorder». Journal of Clinical Psychiatry. 69 Suppl E1: 4–7
100
Merzenich MM, Nelson RJ, Stryker MP, Cynader MS, Schoppmann A, Zook JM. Somatosensory cortical map changes following digit amputation in adult monkeys. J Comp Neurol. 1984; 224(4): 591–605.
101
Davidson RJ, McEwen BS. Social influences on neuroplasticity: Stress and interventions to promote well-being. Nature neuroscience. 2012; 15(5): 689–695. doi: 10.1038/nn. 3093
102
Castrén E, Rantamäki T. Neurotrophins in depression and antidepressant effects. Novartis Found Symp. 2008; 289: 43–52
103
Castrén E, Rantamäki T. The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol. 2010; 70(5): 289–97
104
Goldman-Rakic PS (October 1996). The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 351(1346): 1445–53
105
X. T. Wang and Robert D. Dvorak. Sweet Future: Fluctuating Blood Glucose Levels Affect Future Discounting. Psychological Science, 21, 183–188
106
Maes M. «Functional» or «psychosomatic» symptoms, e. g. a flu-like malaise, aches and pain and fatigue, are major features of major and in particular of melancholic depression. Neuro Endocrinol Lett. 2009; 30(5): 564–73
107
Ryan KA, Dawson EL, Kassel MT, et al. Shared dimensions of performance and activation dysfunction in cognitive control in females with mood disorders. Brain. 2015; 138(Pt 5): 1424–34
108
Mackin P, Young AH, The Role of Cortisol and Depression: Exploring New Opportunities for Treatments, Psychiatric Times, 2004; 21: 92–5
109
Касьянов Е. Д., Мазо Г. Э. Функционирование гипоталамо-гипофизарно-надпочечниковой оси при депрессии: актуальное состояние проблемы. // Психическое здоровье. 2017. № 8. С. 27–34.
110
Herbert J. Cortisol and depression: three questions for psychiatry. Psychol Med. 2013; 43(3): 449–69.
111
Sapolsky RM. Depression, antidepressants, and the shrinking hippocampus. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98(22): 12320–12322
112
D'Mello, C., and Swain, M. G. (2017). Immune-to-brain communication pathways in inflammation-associated sickness and depression. Curr.
113
https://www.nature.com/articles/s41398–021–01302–0?utm_medium=affiliate&utm_source=commission_junction&utm_campaign=3_nsn6445_deeplink_PID100029727&utm_content=deeplink.
114
Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010. Hay PJ, ed. PLoS Medicine. 2013; 10(11): e1001547
115
Соломон Э. Демон полуденный: Анатомия депрессии. — М.: Добрая книга, 2004
116
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0169764
117
Lorant V, Deliege D, Eaton W, Robert A, Philippot P, Ansseau M. Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol. 2003;157:98–112.
118
Jonassen R, Chelnokova O, Harmer C, Leknes S, Landrø NI. A single dose of antidepressant alters eye-gaze patterns across face stimuli in healthy women. Psychopharmacology (Berl). 2015; 232(5): 953–8.
119
Selikoff IJ, Robitzek EH. Tuberculosis chemotherapy with hydrazine derivatives of isonicotinic acid. Dis Chest. 1952; 21(4): 385–438
120
Burn JH. The Antihistamine Compounds. British Medical Journal. 1958; 2(5100): 845–846
121
Pletscher A. The discovery of antidepressants: a winding path. Experientia. 1991; 47(1): 4–8
122
Fagius J, Osterman PO, Sidén A, Wiholm BE. Guillain-Barré syndrome following zimeldine treatment. Journal of Neurology, Neurosurgery, and Psychiatry. 1985; 48(1): 65–69
123
Barbey JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry. 1998; 59 Suppl 15: 42–8
124
Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry. 2006; 163(1): 41–7
125
Dunlop BW, Davis PG. Combination Treatment With Benzodiazepines and SSRIs for Comorbid Anxiety and Depression: A Review. Primary Care Companion to The Journal of Clinical Psychiatry. 2008; 10(3): 222–228
126
Постановление Правительства Российской Федерации от 4 февраля 2013 г. № 78 г. Москвы «О внесении изменений в некоторые акты Правительства Российской Федерации».
127
Boyce P, Judd F. The place for the tricyclic antidepressants in the treatment of depression. Aust N Z J Psychiatry. 1999; 33(3): 323–7
128
Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, Severity, and Comorbidity of Twelve-month DSM — IV Disorders in the National Comorbidity Survey Replication (NCS-R). Archives of general psychiatry. 2005; 62(6): 617–627. doi: 10.1001/archpsyc.62.6.617
129
Machado M, Einarson TR. Comparison of SSRIs and SNRIs in major depressive disorder: a meta-analysis of head-to-head randomized clinical trials. J Clin Pharm Ther. 2010; 35(2): 177–88
130
Nieuwstraten CE, Dolovich LR. Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression. Ann Pharmacother. 2001; 35(12): 1608–13
131
Pagnin D, De queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a meta-analytic review. J ECT. 2004; 20(1): 13–20
132
Food and Drug Administration — Управление по санитарному надзору за качеством продуктов и медикаментов
133
https://www.nature.com/articles/npp2016210.
134
https://pubmed.ncbi.nlm.nih.gov/29802366/.
135
https://www.medscape.com/viewarticle/917874?src=android&devicetype=android&osversion=9&appversion=6.2.2&&src=medscapeapp-android&ref=share.
136
Razza LB, Palumbo P, Moffa AH, et al. A systematic review and meta-analysis on the effects of transcranial direct current stimulation in depressive episodes. Depression and Anxiety. 2020;1–15.
137
Beltman MW, Voshaar RC, Speckens AE. Cognitive-behavioural therapy for depression in people with a somatic disease: meta-analysis of randomised controlled trials. Br J Psychiatry. 2010; 197(1): 11–9
138
Hofmann SG, Smits JA. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008; 69(4): 621–32
139
U. S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health. (2015). Mental Health Information: Depression. Retrieved from http://www.nimh.nih.gov/health/topics/depression/index.shtml.
140
Manber R, Kraemer HC, Arnow BA, et al. Faster Remission of Chronic Depression With Combined Psychotherapy and Medication Than With Each Therapy Alone. Journal of consulting and clinical psychology. 2008; 76(3): 459–467. doi: 10.1037/0022–006X.76.3.459.
141
Lemmens LH, Arntz A, Peeters F, Hollon SD, Roefs A, Huibers MJ. Clinical effectiveness of cognitive therapy v. interpersonal psychotherapy for depression: results of a randomized controlled trial. Psychol Med. 2015; 45(10): 2095–110.
142
Gilbert, P., and Procter, S. (2006). Compassionate mind training for people with high shame and self-criticism: overview and pilot study of a group therapy approach. Clin. Psychol. Psychother. 13, 353–379. doi: 10.1002/cpp.507.
143
Shapira, L. B., and Mongrain, M. (2010). The benefits of self-compassion and optimism exercises for individuals vulnerable to depression. J. Posit. Psychol. 5, 377–389. doi: 10.1080/17439760.2010.516763
144
Goodwin FK, Jamison KR. Manic-depressive illness: bipolar disorders and recurrent depression. 2. New York: Oxford University Press; 2007
145
Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord. 2003; 73(1–2): 123–31
146
Roccatagliata G. A History of Ancient Psychiatry. Praeger Pub Text; 1986. (pp. 230–231).
147
Solomon DA, Leon AC, Coryell WH, et al. Longitudinal course of bipolar I disorder: duration of mood episodes. Arch Gen Psychiatry. 2010; 67(4): 339–47
148
Fellinger M, Waldhoer T, König D, et al. Seasonality in bipolar disorder: Effect of sex and age [published online September 20, 2018]. J Affect Disord.
149
Jamison KR. An Unquiet Mind, A Memoir of Moods and Madness. Vintage; 2009, p. 36
150
Jamison KR. Suicide and Bipolar Disorder. J Clin Psychiatry 2000; 61 (Suppl 9): 47–51.
151
Solomon DA, Leon AC, Coryell WH, et al. Longitudinal course of bipolar I disorder: duration of mood episodes. Arch Gen Psychiatry. 2010; 67(4): 339–47.
152
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838621/
153
Kasyanov ED, Merculova TV, Kibitov AO, Mazo GE. Genetics of bipolar spectrum disorders: focus on family studies using whole exome sequencing // Genetica [Russian Journal of Genetics]. 2020. V. 56. № 7. P. 762–782.
154
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013; 381(9875): 1371–9
155
Stein DJ, Kupfer DJ, Schatzberg AF. The American Psychiatric Publishing Textbook of Mood Disorders. American Psychiatric Pub; 2007: 159–75
156
Alloy LB, Nusslock R, Boland EM. Annu Rev Clin Psychol 2015; 11: 213–50.
157
Siegel D. Mindsight, Transform Your Brain with the New Science of Kindness. Oneworld Publications; 2010: 80–101
158
https://pubmed.ncbi.nlm.nih.gov/28461699/
159
Nusslock R, Alloy LB. J Affect Disord 2017; 216: 3–16
160
https://www.nature.com/articles/s41380–021–01091–4.
161
J. R. Whitwell, Historical Notes on Psychiatry. London: Lewis, 1936.
162
Andreasen NC. The relationship between creativity and mood disorders. Dialogues in Clinical Neuroscience. 2008; 10(2): 251–255
163
Jamison KR. Mood disorders and patterns of creativity in British writers and artists. Psychiatry. 1989; 52(2): 125–34
164
Ludwig AM. Creative achievement and psychopathology: comparison among professions. Am J Psychother. 1992; 46(3): 330–56
165
Santosa CM, Strong CM, Nowakowska C, Wang PW, Rennicke CM, Ketter TA. Enhanced creativity in bipolar disorder patients: a controlled study. J Affect Disord. 2007; 100(1–3): 31–9
166
Kyaga S, Lichtenstein P, Boman M, Hultman C, Långström N, Landén M. Creativity and mental disorder: family study of 300,000 people with severe mental disorder. Br J Psychiatry. 2011;199(5): 373–9
167
Frederick K. Googwin, Kay Redfield Jamison. Manic-depressive ilness. Bipolar disorders and reccurent depression. Oxford University Press 2007
168
Figueroa c G. [Virginia Woolf as an example of a mental disorder and artistic creativity]. Rev Med Chil. 2005; 133(11): 1381–8
169
Ta-Wei Guu, Kuan-Pin Su. Musical creativity and mood bipolarity in Robert Schumann: A tribute on the 200th anniversary of the composer's birth. Psychiatry and Clinical Neurosciences 2011; 65: 112–114
170
Stephen G. Michaud, Hugh Aynesworth. The Only Living Witness: The True Story of Serial Sex Killer Ted Bundy
171
M. Fink, Delirious mania. Bipolar Disorders, vol. 1, no. 1, pp. 54–60, 1999
172
Fazel S, Lichtenstein P, Grann M, Goodwin GM, Långström N. Bipolar disorder and violent crime: new evidence from population-based longitudinal studies and systematic review. Arch Gen Psychiatry. 2010;67(9): 931–8.
173
https://www.psychologytoday.com/blog/inside-the-criminal-mind/201105/bipolar-illness-or-the-ups-and-downs-the-antisocial-persons
174
Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin K. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?. J Affect Disord. 1999; 52(1–3): 135–44
175
Pacchiarotti I, Bond DJ, Baldessarini RJ, et al. The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders. The American journal of psychiatry. 2013; 170(11): 1249–1262. doi: 10.1176/appi.ajp.2013.13020185.
176
Tohen M, Zarate CA, Hennen J, et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry. 2003; 160(12): 2099–107.
177
Simhandl C, König B, Amann BL. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients. J Clin Psychiatry. 2014; 75(3): 254–62
178
Baethge C, Baldessarini RJ, Mathiske-schmidt K, et al. Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. J Clin Psychiatry. 2005; 66(2): 174–82.
179
Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. International Journal of Bipolar Disorders. 2014; 2: 15. doi: 10.1186/s40345–014–0015–8.
180
Van der loos ML, Kölling P, Knoppert-van der klein EA, Nolen WA. [Lamotrigine in the treatment of bipolar disorder, a review]. Tijdschr Psychiatr. 2007; 49(2): 95–103.
181
Rapoport SI, Basselin M, Kim HW, Rao JS. Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev. 2009; 61(2): 185–209.
182
Macritchie K, Geddes JR, Scott J, Haslam D, De lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev. 2003; (1): CD004052.
183
Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009; 194(1): 4–9.
184
Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. International Journal of Bipolar Disorders. 2014;2:15. doi: 10.1186/s40345–014–0015–8.
185
Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009; 194 (1): 4–9.
186
Macritchie K, Geddes JR, Scott J, Haslam D, De lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev. 2003; (1): CD004052
187
Ushkalova AV, Kostiukova EG, Mosolov SN. [A comparative study of different types of pharmacotherapy in treatment of depressive phase of bipolar II disorder]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015; 115(1 Vypusk 2 Depressiia): 23–30
188
189
Zaretsky AE, Rizvi S, Parikh SV. How well do psychosocial interventions work in bipolar disorder?. Can J Psychiatry. 2007;5 2(1): 14–21
190
Frank E, Swartz HA, Mallinger AG, Thase ME, Weaver EV, Kupfer DJ. Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. J Abnorm Psychol. 1999;108(4): 579–87.
191
Miklowitz DJ. The Bipolar Disorder Survival Guide, Second Edition, What You and Your Family Need to Know. Guilford Press; 2011
192
Braga RJ, Burdick KE, Derosse P, Malhotra AK. Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder. Psychiatry Res. 2012; 200(2–3):242–5
193
Steimer T. The biology of fear- and anxiety-related behaviors. Dialogues in Clinical Neuroscience. 2002; 4(3): 231–249.
194
Ohman A, Lundqvist D, Esteves F. The face in the crowd revisited: a threat advantage with schematic stimuli. J Pers Soc Psychol. 2001; 80 (3): 381–96
195
Pittman CM, Karle EM. Rewire Your Anxious Brain, How to Use the Neuroscience of Fear to End Anxiety, Panic, and Worry. New Harbinger Publications Incorporated; 2014:16–24.
196
Гоулман Д. Эмоциональный интеллект. — М.: ACT, 2009.
197
Amunts K, Kedo O, Kindler M, et al. Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: intersubject variability and probability maps. Anat Embryol. 2005; 210(5–6): 343–52.
198
Ledoux J. The emotional brain, fear, and the amygdala. Cell Mol Neurobiol. 2003; 23(4–5): 727–38.
199
Tillich P, Gomes PJ. The Courage to be. New Haven [Conn.]: Yale University Press, 2000
200
World Health Organization. Global health estimates 2014 summary tables: YLD estimates, 2000–2012, Available: http://www.who.int/entity/healthinfo/global_burden_disease/GHE_YLD_Global_2000_2012.xls. Accessed 8 March 2010.
201
Dupont RL, Rice DP, Miller LS, Shiraki SS, Rowland CR, Harwood HJ. Economic costs of anxiety disorders. Anxiety. 1996; 2(4): 167–72.
202
Lamers F, Van oppen P, Comijs HC, et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2011; 72(3): 341–8.
203
Kessler RC, Berglund PA, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM — IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry.2005 Jun; 62(6): 593–602.
204
King, Helen (1993). «Once upon a text: Hysteria from Hippocrates». In Gilman, Sander; King; Porter, Helen; Rousseau, G.S.; Showalter, Elaine. Hysteria beyond Freud. University of California Press.
205
May R. The Meaning of Anxiety. W. W. Norton; 2015: 40–67.
206
Там же.
207
Kyaga S, Landén M, Boman M, Hultman CM, Långström N, Lichtenstein P. Mental illness, suicide and creativity: 40-year prospective total population study. J Psychiatr Res. 2013 47(1): 83–90.
208
Silvia, P. J., & Kimbrel, N. A. (in press). A dimensional analysis of creativity and mental illness: Do anxiety and depression symptoms predict creative cognition, creative accomplishments, and creative self-concepts? Psychology of Aesthetics, Creativity, and the Arts.
209
Dommermuth-Costa C. Nikola Tesla, A Spark of Genius. Twenty-First Century Books; 1994: 19–21.
210
Jerry Bergman, Ph.D. 2004. Was Charles Darwin Psychotic? A Study of His Mental Health. Acts & Facts. 33 (1).
211
Panter B, Virshup B. Psychological Studies of Art and Artists. 1996.
212
Фрейд З. Введение в психоанализ. Лекции. — СПб.: Азбука, 2014
213
Izard CE. The Psychology of Emotions. Springer; 2004. 308–12.
214
Klein DF. Historical aspects of anxiety. Dialogues in Clinical Neuroscience. 2002; 4(3): 295–304.
215
Cordain L, Eaton SB, Sebastian A, et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005; 81(2): 341–54.
216
Grinde B. An approach to the prevention of anxiety-related disorders based on evolutionary medicine. Prev Med. 2005; 40(6): 904–9.
217
Price JS. Evolutionary aspects of anxiety disorders. Dialogues in Clinical Neuroscience. 2003; 5(3): 223–236
218
Watson JB, Rayner R. Conditioned emotional reactions. 1920. Am Psychol. 2000; 55(3): 313–7
219
Beck, H. P., Levinson, S., & Irons, G. (2009). «Finding Little Albert: A journey to John B. Watson's infant laboratory». American Psychologist, 64, 7.
220
Etkin A, Prater KE, Schatzberg AF, Menon V, Greicius MD. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Arch Gen Psychiatry. 2009; 66(12): 1361–72
221
Adolphs R, Tranel D, Hamann S, et al. Recognition of facial emotion in nine individuals with bilateral amygdala damage. Neuropsychologia. 1999; 37(10): 1111–7.
222
Haygarth, John. (1800). Of the imagination, as a cause and as a cure of disorders of the body; exemplified by fictitious tractors, and epidemical convulsions. Read to the Literary and Philosophical Society of Bath. By John Haygarth, M.D. … Bath: printed by R. Cruttwell; and sold by Cadell and Davies, London.
223
Lydiard RB. The role of GABA in anxiety disorders. J Clin Psychiatry. 2003; 64 Suppl 3: 21–7.
224
Stein MB, Goin MK, Pollack MH, Roy-Byrne P, Sareen J, Simon NM, et al. Practice guideline for the treatment of patients with panic disorder. Arlington, VA: American Psychiatric Association, 2009
225
Association, American Psychiatric (2013). Diagnostic and statistical manual of mental disorders: DSM — V. (5th ed.). Washington, D.C.: American Psychiatric Association. p. 222
226
Heinze HJ, Mangun GR, Burchert W, et al. Combined spatial and temporal imaging of brain activity during visual selective attention in humans. Nature. 1994; 372(6506): 543–6
227
Bateson M, Brilot B, Nettle D. Anxiety: an evolutionary approach. Can J Psychiatry. 2011; 56(12): 707–15
228
Lundström JN, Olsson MJ. Functional Neuronal Processing of Human Body Odors. Vitamins and hormones. 2010; 83: 1–23. doi: 10.1016/S0083–6729(10)83001–8
229
Morgan E. The Scars of Evolution. Oxford University Press on Demand; 100–1, 1994.
230
Taylor, C. B., Sheikh, J., Agras, S., Roth, W. T., Margraf, J., Ehlers, A., Maddock, R. J., & Gossard, D. (1986). Ambulatory heart rate changes in patients with panic attacks. American Journal of Psychiatry, 143, 478–482.
231
O'Mahony, J… & Ward, B.. (2003). Differences between those who panic by day and those who also panic by night. Journal of Behavior Therapy and Experimental Psychiatry, 34(3–4), 239–249.
232
Depersonalization: A New Look at a Neglected Syndrome By Mauricio Sierra, p. 154
233
Favazza, A. (2012). Nonsuicidal self-injury: How categorization guides treatment. Current Psychiatry, 11, 21–26
234
Prodigal Genius: The Life of Nikola Tesla By John J. O'Neil, 293.
235
Wilson, Bee, The Telegraph, «Alfred Hitchcock's complicated relationship with food,» (http://www.telegraph.co.uk/journalists/bee-wilson/9818987/Alfred-Hitchcocks-complicated-relationship-with-food.html), March 8, 2016.
236
Salvador Dal', Or the Art of Spitting on Your Mother's Portrait By Carlos Rojas, p. 46.
237
Rapee RM. Family factors in the development and management of anxiety disorders. Clin Child Fam Psychol Rev. 2012; 15 (1): 69–80.
238
Kendler K, Karkowski L, Prescott C (1999). «Fears and phobias: reliability and heritability». Psychological Medicine 29 (3): 539–53.
239
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM — IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6): 593–602.
240
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM — IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6): 593–602.
241
Брайсон Б. Краткая история почти всего на свете. — М.: АСТ, 2016
242
Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006; 63(4): 415.
243
Yardley L, Britton J, Lear S, Bird J, Luxon LM. Relationship between balance system function and agoraphobic avoidance. Behav Res Ther. 1995; 33(4): 435–9
244
Jacob RG, Furman JM, Durrant JD, Turner SM. Panic, agoraphobia, and vestibular dysfunction. Am J Psychiatry. 1996; 153(4): 503–12
245
Bisson, J. I., Cosgrove, S., Lewis, C., & Roberts, N. P. (2015). Post-traumatic stress disorder. BMJ, h6161.
246
Shin LM, Shin PS, Heckers S, et al. Hippocampal function in posttraumatic stress disorder. Hippocampus. 2004; 14(3): 292–300
247
Skelton K, Ressler KJ, Norrholm SD, Jovanovic T, Bradley-davino B. PTSD and gene variants: new pathways and new thinking. Neuropharmacology. 2012; 62(2): 628–37
248
Van der kolk B. Posttraumatic stress disorder and the nature of trauma. Dialogues Clin Neurosci. 2000; 2(1): 7–22
249
МКБ-11.
250
Hirschfeld RMA. The Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary Care. Primary Care Companion to The Journal of Clinical Psychiatry. 2001; 3(6): 244–254
251
Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Major depression and generalized anxiety disorder. Same genes, (partly) different environments? Arch Gen Psychiatry. 1992; 49(9): 716–22
252
Allgulander C, Bandelow B, Hollander E, et al. WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectr. 2003; 8(8 Suppl 1): 53–61
253
Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. J Affect Disord. 2000; 59(2): 119–26
254
Clapp P, Bhave SV, Hoffman PL. How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective. Alcohol Res Health. 2008; 31(4): 310–39
255
Davies M. The role of GABAA receptors in mediating the effects of alcohol in the central nervous system. Journal of Psychiatry and Neuroscience. 2003; 28(4): 263–274
256
Smith JP, Randall CL. Anxiety and alcohol use disorders: comorbidity and treatment considerations. Alcohol Res. 2012; 34(4): 414–31
257
McGovern TF, White WL. Alcohol Problems in the United States, Twenty Years of Treatment Perspective. Haworth Press; 2002; 5–40
258
Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry. 2013; 12(2): 137–48
259
Otte C. Cognitive behavioral therapy in anxiety disorders: current state of the evidence. Dialogues in Clinical Neuroscience. 2011; 13(4): 413–421.
260
Перевод клинических рекомендаций по лечению панического расстройства Американской психиатрической ассоциации, подготовленный совместными усилиями научного интернет-портала «Психиатрия & Нейронауки» и Клиники психиатрии и наркологии «Доктор САН».
261
Там же.
262
МКБ-11.
263
МКБ-11.
264
Cognitive Processes and Biases in Obsessive-Compulsive Disorder By Elisa Krackow, Sarah Nunley and Pamela Tessier Submitted: September 12th 2013Reviewed: February 24th 2014Published: April 3rd 2014.
265
Rachman SS. A cognitive theory of compulsive checking. Behaviour Research & Therapy, 2002; 40(6) 625.
266
Aardema, F., Doron, G., Melli, G., Radomsky, A. S., Audet, J. S., & Lalonde, M. P. (2017). The role of feared possible selves in obsessive — compulsive and related disorders: A comparative analysis of a core cognitive self-construct in clinical samples. Clinical Psychology & Psychotherapy, 25(1), 19–30.
267
Tanya L Godwin, Hayward J Godwin, Laura M Simonds. What is the relationship between fear of self, self-ambivalence, and obsessive-compulsive symptomatology? A systematic literature review.
268
Summerfeldt LJS, Kloosterman PH, Antony MM and Swinson RP (2014). Examination of an obsessive-compulsive core dimensions model: structural validity of harm avoidance and incompleteness. Journal of Obsessive-Compulsive and Related Disorders 3, 83–94.
269
van den Hout, MA., van Dis, EA., van Woudenberg, C., and van de Groep, I. H. (2017). OCD-like checking in the lab: A meta-analysis and improvement of an experimental paradigm. Journal of Obsessive-Compulsive and Related Disorders 20, 39–49.
270
Dek ECP, van den Hout MA, Engelhard IM, Giele CL and Cath DC (2015). Perseveration causes automatization of checking behavior in obsessive-compulsive disorder. Behaviour Research and Therapy 71, 1–9.
271
Taylor J and Purdon C (2016). Responsibility and hand washing. Journal of Behavior Therapy and Experimental Psychiatry 51, 43–50.
272
https://news.mit.edu/2020/study-commercial-flights-safer-ever-0124.
273
Szechtman H and Woody E (2004). Obsessive-compulsive disorder as a disturbance of security motivation. Psychological Review 111, 111–127.
274
van Megen HJ, den Boer-Wolters D, Verhagen PJ (2010). «Obsessive compulsive disorder and religion: a reconnaissance». In Verhagen P, Van Praag HM, López-Ibor JJ Jr, Cox J, Moussaoui D (eds.). Religion and Psychiatry: Beyond Boundaries. Wiley, pp. 271–82.
275
Aho JA (2005). «Martin Luther and scrupulosity». Confession and Bookkeeping: the Religious, Moral, and Rhetorical Roots of Modern Accounting. Albany: State University of New York Press, pp. 95–8.
276
277
Минутко В. Навязчивые состояния. — Курск: ООО «ПЛАНЕТА +», 2011.
278
Davies M. The role of GABAA receptors in mediating the effects of alcohol in the central nervous system. Journal of Psychiatry and Neuroscience. 2003; 28(4): 263–274
279
https://www.thelancet.com/journals/lancet/article/PIIS0140–6736(09)60240–3/fulltext.
280
https://www.nature.com/articles/s41467–017–00831-x.
281
https://www.nature.com/articles/4001365.
282
Streptococcal Infections and Exacerbations in PANDAS: A Systеmatic Review and Meta-analysis. Nielsen MØ, Köhler-Forsberg O, Hjorthøj C, Benros ME, Nordentoft..
283
https://www.scielo.br/j/trends/a/kcDVrBpT6Bf3rh3B8Chnwcf/?format=pdf&lang=en.
284
McGrath MJ, Campbell KM, Parks CR, Burton FH. Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder. Brain Res. 2000; 15; 877: 23–30.
285
Anna M. Wehry, Katja Beesdo-Baum. Assessment and Treatment of Anxiety Disorders in Children and Adolescents. Curr Psychiatry Rep. 2015 Jul; 17(7): 591.
286
«Клинические рекомендации по лечению обсессивно-компульсивного расстройства» Американской психиатрической ассоциации (в переводе научного интернет-портала «Психиатрия & Нейронауки» и Клиники психиатрии «Доктор САН»).
287
Somnath Banerjee (2012). ADHD in Children and Adolescents: A Good Practice Guidance, Current Directions in ADHD and Its Treatment, Dr. Jill M. Norvilitis (Ed.).
288
Ratey NA. The Disorganized Mind, Coaching Your ADHD Brain to Take Control of Your Time, Tasks, and Talents. St. Martin's Press, 2008.
289
Hodgkins P, Arnold LE, Shaw M, et al. A Systematic Review of Global Publication Trends Regarding Long-Term Outcomes of ADHD. Frontiers in Psychiatry. 2011; 2: 84.
290
Lange KW, Reichl S, Lange KM, Tucha L, Tucha O. The history of attention deficit hyperactivity disorder. Attention Deficit and Hyperactivity Disorders. 2010; 2(4): 241–255.
291
Ratey NA. The Disorganized Mind, Coaching Your ADHD Brain to Take Control of Your Time, Tasks, and Talents. St. Martin's Press, 2008.
292
Lange KW, Reichl S, Lange KM, Tucha L, Tucha O. The history of attention deficit hyperactivity disorder. Attention Deficit and Hyperactivity Disorders. 2010; 2(4): 241–255
293
Strohl MP. Bradley's Benzedrine Studies on Children with Behavioral Disorders. The Yale Journal of Biology and Medicine. 2011; 84(1): 27–33
294
Myers RL. The 100 Most Important Chemical Compounds, A Reference Guide. ABC–CLIO; 2007: 178–80.
295
Cosgrove L, Krimsky S, Vijayaraghavan M, Schneider L. Financial ties between DSM — IV panel members and the pharmaceutical industry. Psychother Psychosom. 2006;75(3): 154–60
296
Americans With Disabilities Act of 1990, Pub. L. No. 101–336, 104 Stat. 328 (1990)
297
Kessler, R.C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., Howes, M.J., Jin, R., Secnik, K., Spencer, T., Ustun, T.B., Walters, E.E. (2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS). Psychological Medicine, 35(2), 245–25
298
Kooij SJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010; 10: 67
299
Arria AM, Wish ED. Nonmedical Use of Prescription Stimulants Among Students. Pediatric annals. 2006; 35(8): 565–571
300
Garnier-Dykstra LM, Caldeira KM, Vincent KB, O'Grady KE, Arria AM. Nonmedical use of prescription stimulants during college: Four-year trends in exposure opportunity, use, motives, and sources. Journal of American College Health: J of ACH. 2012; 60(3): 226–234
301
Taylor FB, Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol. 2000; 10(4): 311–20
302
Faraone SV. Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in Youths. P T. 2009; 34(12): 678–94
303
Ginsberg Y, Quintero J, Anand E, Casillas M, Upadhyaya HP. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. Prim Care Companion CNS Disord. 2014; 16(3).
304
Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet. 2009; 126(1): 51–90
305
Mccarthy H, Skokauskas N, Mulligan A, et al. Attention network hypoconnectivity with default and affective network hyperconnectivity in adults diagnosed with attention-deficit/hyperactivity disorder in childhood. JAMA Psychiatry. 2013; 70(12): 1329–37
306
Safer DJ, Krager JM. Treatment of Attention-Deficit Hyperactivity Disorder-Reply. JAMA. 1993; 269(18): 2369
307
Maraini D, Dacia Maraini Intervista Giorgio Antonucci. La Stampa, 26.7., 29 e 30.12.'78
308
Moffitt T, Melchior M. Why does the worldwide prevalence of childhood attention deficit hyperactivity disorder matter? The American Journal of Psychiatry. 2007; 146(6): 856–858. doi: 10.1176/appi.ajp.164.6.856
309
Shaw, P., Malek, M., Watson, B., Greenstein, D., de Rossi, P., & Sharp, W. (2013). Trajectories of Cerebral Cortical Development in Childhood and Adolescence and Adult Attention-Deficit/Hyperactivity Disorder, Biological Psychiatry, 74, 599–606
310
Sripada CS, Kessler D, Angstadt M. Lag in maturation of the brain's intrinsic functional architecture in attention-deficit/hyperactivity disorder. Proc Natl Acad Sci USA. 2014; 111(39): 14259–64
311
Volkow ND, Wang G-J, Newcorn JH, et al. Motivation Deficit in ADHD is Associated with Dysfunction of the Dopamine Reward Pathway. Molecular psychiatry. 2011;16(11): 1147–1154. doi: 10.1038/mp.2010.97
312
Голдберг Э. Управляющий мозг: Лобные доли, лидерство и цивилизация. — М.: Смысл, 2003
313
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477352/.
314
https://www.frontiersin.org/articles/10.3389/fphys.2020.583005/full.
315
Archer D. The ADHD Advantage, What You Thought Was a Diagnosis May Be Your Greatest Strength. Hudson Street Press; 2015
316
https://www.nature.com/articles/s41588–018–0269–7.
317
https://www.nature.com/articles/s41593–019–0527–8.
318
Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry. 2002; 41 (4): 378–85.
319
Hartmann T. Attention Deficit Disorder, A Different Perception. Underwood Books; 1997
320
https://onlinelibrary.wiley.com/doi/abs/10.1002/ajpa.21358.
321
Eisenberg et al., 2008. Dopamine receptor genetic polymorphisms and body composition in undernourished pastoralists: An exploration of nutrition indices among nomadic and recently settled Ariaal men of northern Kenya. // BMC Evolutionary Biology, 8.
322
Archer D. The ADHD Advantage, What You Thought Was a Diagnosis May Be Your Greatest Strength. Hudson Street Press; 2015
323
Gilman L, Career Advice from the Corner Office: Famous People with ADHD, ADDitude, 2005 Dec-Jan.
324
Адералл — лекарство от СДВГ, схоже с риталином.
325
Archer D. The ADHD Advantage, What You Thought Was a Diagnosis May Be Your Greatest Strength. Hudson Street Press; 2015.
326
Holly A. White. Thinking «Outside the Box»: Unconstrained Creative Generation in Adults with Attention Deficit Hyperactivity Disorder. The Journal of Creative Behavior, 2018.
327
World Health Organization (2012). Pharmacological and nonpharmacological interventions for children with attention-deficit hyperactivity disorder (ADHD). Geneva: WHO
328
Philipsen A, Richter H, Peters J, et al. Structured group psychotherapy in adults with attention deficit hyperactivity disorder: results of an open multicentre study. J Nerv Ment Dis. 2007; 195(12): 1013–9.
329
Weiss M, Murray C, Wasdell M, Greenfield B, Giles L, Hechtman L. A randomized controlled trial of CBT therapy for adults with ADHD with and without medication. BMC Psychiatry. 2012; 12:30. doi: 10.1186/1471–244X-12–30.
330
Morton WA, Stockton GG. Methylphenidate Abuse and Psychiatric Side Effects. Primary Care Companion to The Journal of Clinical Psychiatry. 2000; 2(5): 159–164.
331
Faraone SV, Biederman J, Spencer TJ, Aleardi M. Comparing the Efficacy of Medications for ADHD Using Meta-analysis. Medscape General Medicine. 2006; 8(4): 4.
332
Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther. 2005; 43(7): 831–42
333
Michelson D., Faries D., Wernicke J. et al. Atomoxetine in the treatment of children and adolescents with attention-deficity hyperactivity disorder: a randomised, placebo-controlled, dose-response study // Pediatrics. 2001. № 108. P. 1–9.
334
Tor-Arne Hegvik, Kai Waloen, Sunil K. Pandey, Stephen V. Faraone, Jan Haavik, Tetyana Zayats. Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment. Molecular Psychiatry.
335
Зиновьева А. Космический пришелец по имени Иван // Московский комсомолец. — 2013. — 5 июля (№ 26272).
336
Schechter MD, Timmons GD. Objectively measured hyperactivity — II. Caffeine and amphetamine effects. J Clin Pharmacol. 1985; 25(4): 276–80.
337
Arnold LE, Christopher J, Huestis R, Smeltzer DJ. Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis. Arch Gen Psychiatry. 1978; 35(4): 463–73.
338
Archer D. The ADHD Advantage, What You Thought Was a Diagnosis May Be Your Greatest Strength. Hudson Street Press; 2015
339
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538574/.
340
В этой главе мы решили не писать про аутизм в целом (хотя это, безусловно, интересная и заслуживающая внимания тема), а сконцентрироваться на высокофункциональном аутизме и синдроме Аспергера. С точки зрения стороннего наблюдателя, именно эти варианты расстройства ближе всего к «нормальности», их носители более или менее интегрированы в общество и визуально мало чем отличаются от обычных людей — и, соответственно, они с большой вероятностью могут встретиться среди ваших коллег, соседей и друзей. Притом от них ожидают того же, что и от обычных людей, поэтому неожиданные проявления их особенностей могут вызвать серьезное непонимание.
341
Wing L. The history of ideas on autism: Legends, myths and reality. Autism. 1997; 1: 13–23.
342
Miles, M. «Martin Luther and Childhood Disability in 16th Century Germany: What Did He Write? What Did He Say?» Journal of Religion, Disability, and Health 5, no. 4: 5–36.
343
Houston R, Frith U. Autism in History, The Case of Hugh Blair of Borgue. Wiley-Blackwell; 2000.
344
Rapaport, David, (1951). Organization and pathology of thought: Selected sources., (pp. 399–437). New York, NY, US: Columbia University Press, xviii, 786 pp.
345
Baron-Cohen S, Klin A. What's so special about Asperger Syndrome?. Brain Cogn. 2006; 61(1): 1–4.
346
Wing L. Asperger's syndrome: a clinical account. Psychol Med. 1981; 11(1): 115–29.
347
Silberman S. NeuroTribes, The Legacy of Autism and How to Think Smarter About People Who Think Differently. 2016.
348
Feinstein A. A History of Autism, Conversations with the Pioneers. Wiley-Blackwell; 2010.
349
Peek K., Inspiration for 'Rain Man,' Dies at 58, The New York Times, December 27, 2009, A30.
350
Treffert DA. The savant syndrome and autistic disorder. CNS Spectr. 1999; 4(12): 57–60.
351
Klin A. [Autism and Asperger syndrome: an overview]. Rev Bras Psiquiatr. 2006; 28 Suppl 1: S3–11.
352
Там же.
353
Roy M, Dillo W, Emrich HM, Ohlmeier MD. Asperger's syndrome in adulthood. Dtsch Arztebl Int. 2009; 106(5): 59–64.
354
Rogers SJ, Ozonoff S. Annotation: what do we know about sensory dysfunction in autism? A critical review of the empirical evidence. J Child Psychol Psychiatry. 2005; 46(12): 1255–68.
355
Allely CS. Pain Sensitivity and Observer Perception of Pain in Individuals with Autistic Spectrum Disorder. The Scientific World Journal. 2013; 2013: 916178.
356
Green D, Baird G, Barnett AL, Henderson L, Huber J, Henderson SE. The severity and nature of motor impairment in Asperger's syndrome: a comparison with specific developmental disorder of motor function. J Child Psychol Psychiatry. 2002; 43(5): 655–68.
357
Blakemore SJ, Tavassoli T, Calò S, et al. Tactile sensitivity in Asperger syndrome. Brain Cogn. 2006; 61(1): 5–13.
358
Lugnegård T, Hallerbäck MU, Gillberg C. Psychiatric comorbidity in young adults with a clinical diagnosis of Asperger syndrome. Res Dev Disabil. 2011; 32(5): 1910–7.
359
Miles JH, McCathren RB, Stichter J, et al. Autism Spectrum Disorders. 2003 Aug 27 [Updated 2010 Apr 13]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2016. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1442/
360
South M, Ozonoff S, Mcmahon WM. Repetitive behavior profiles in Asperger syndrome and high-functioning autism. J Autism Dev Disord. 2005; 35(2): 145–58.
361
Boyd BA, McDonough SG, Bodfish JW. Evidence-Based Behavioral Interventions for Repetitive Behaviors in Autism. Journal of autism and developmental disorders. 2012; 42(6): 1236–1248.
362
Newman SS, Ghaziuddin M. Violent crime in Asperger syndrome: the role of psychiatric comorbidity. J Autism Dev Disord. 2008; 38(10): 1848–52.
363
Mouridsen SE, Rich B, Isager T, Nedergaard NJ. Pervasive developmental disorders and criminal behaviour: a case control study. Int J Offender Ther Comp Criminol. 2008; 52(2): 196–205
364
Mazefsky CA, Herrington J, Siegel M, et al. The Role of Emotion Regulation in Autism Spectrum Disorder RH: Emotion Regulation in ASD. Journal of the American Academy of Child and Adolescent Psychiatry. 2013; 52(7): 679–688. doi: 10.1016/j.jaac.2013.05.006.
365
Ghaziuddin M, Tsai L, Ghaziuddin N. Brief report: violence in Asperger syndrome, a critique. J Autism Dev Disord. 1991; 21(3): 349–54.
366
Castillo M., Asperger's not likely to make people violent, experts emphasize, CBS News, December 17, 2012.
367
Baez S, Rattazzi A, Gonzalez-gadea ML, et al. Integrating intention and context: assessing social cognition in adults with Asperger syndrome. Front Hum Neurosci. 2012; 6: 302
368
Zalla T, Sav AM, Stopin A, Ahade S, Leboyer M. Faux pas detection and intentional action in Asperger Syndrome. A replication on a French sample. J Autism Dev Disord. 2009; 39(2): 373–82
369
«The impact of atypical sensory processing on social impairments in autism spectrum disorder».Melissa D. Thye, Haley M. Bednarz, Abbey J. Herringshaw, Emma B. Sartin, Rajesh K. Kana. Developmental Cognitive Neuroscience.
370
Henry O'Connell and Michael Fitzgerald (2003). Did Alan Turing have Asperger's syndrome?. Irish Journal of Psychological Medicine, 20, pp. 28–31
371
Decety J, Moriguchi Y. The empathic brain and its dysfunction in psychiatric populations: implications for intervention across different clinical conditions. Biopsychosoc Med. 2007; 1: 22.
372
Raftery B., How Dan Harmon Drives Himself Crazy Making Community, Wired, 09.2011.
373
Grove R, Baillie A, Allison C, Baron-Cohen S, Hoekstra RA. The latent structure of cognitive and emotional empathy in individuals with autism, first-degree relatives and typical individuals. Molecular Autism. 2014; 5: 42. doi: 10.1186/2040–2392–5–42.
374
Mazza M, Pino MC, Mariano M, et al. Affective and cognitive empathy in adolescents with autism spectrum disorder. Front Hum Neurosci. 2014; 8: 791.
375
Mcintosh DN, Reichmann-decker A, Winkielman P, Wilbarger JL. When the social mirror breaks: deficits in automatic, but not voluntary, mimicry of emotional facial expressions in autism. Dev Sci. 2006; 9(3): 295–302
376
Markram H, Rinaldi T, Markram K. The Intense World Syndrome — an Alternative Hypothesis for Autism. Frontiers in Neuroscience. 2007; 1(1): 77–96. doi: 10.3389/neuro.01.1.1.006.2007
377
Hayashi M, Kato M, Igarashi K, Kashima H. Superior fluid intelligence in children with Asperger's disorder. Brain Cogn. 2008; 66(3): 306–10
378
Baron-Cohen S, Golan O, Ashwin E. Can emotion recognition be taught to children with autism spectrum conditions? Philosophical Transactions of the Royal Society B: Biological Sciences. 2009; 364(1535): 3567–3574.
379
Segar M. Faire face, guide de survie à l'intention des personnes atteintes du syndrome d'Asperger. 1998
380
http://www.aspergers.ru/node/94
381
Willingham D., 'Wall Street' Actress Daryl Hannah Is An Autistic Woman, Forbes, 9.29.2013
382
Shattuck PT, Narendorf SC, Cooper B, Sterzing PR, Wagner M, Taylor JL. Postsecondary education and employment among youth with an autism spectrum disorder. Pediatrics. 2012; 129(6): 1042–9
383
James I. Singular scientists. Journal of the Royal Society of Medicine. 2003; 96(1): 36–39.
384
Ruthsatz, J., & Urbach, J. B., Child prodigy: A novel cognitive profile places elevated general intelligence, exceptional working memory and attention to detail… Intelligence (2012).
385
Baron-Cohen S, Bolton P, Wheelwright S, Scahill V, Short L, Mead G, Smith A. Does autism occur more often in families of physicists, engineers, and mathematicians? Autism. 1998; 2 (3): 296–301
386
Clarke T-K. et al. Common polygenic risk for autism spectrum disorder (ASD) is associated with cognitive ability in the general population. Molecular Psychiatry. 2015. March 10
387
Frith U. Emanuel Miller lecture: confusions and controversies about Asperger syndrome. J Child Psychol Psychiatry. 2004; 45(4): 672–86
388
Grove R, Roth I, Hoekstra RA. The motivation for special interests in individuals with autism and controls: Development and validation of the special interest motivation scale. Autism Res. 2015
389
Prior M, Ozonoff S (2007). «Psychological factors in autism». In Volkmar FR. Autism and Pervasive Developmental Disorders (2nd ed.). Cambridge University Press. pp. 69–128
390
http://youtu.be/i_yJTCDU4uE
391
Freitag CM. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry. 2007; 12(1): 2–22.
392
Persico AM, Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci. 2006; 29(7): 349–58.
393
Courchesne E, Mouton PR, Calhoun ME, et al. Neuron Number and Size in Prefrontal Cortex of Children With Autism. JAMA. 2011; 306(18): 2001–2010.
394
Kanold PO. Subplate neurons: crucial regulators of cortical development and plasticity. Front Neuroanat. 2009; 3: 16.
395
Hadjikhani N, Joseph RM, Snyder J, Tager-flusberg H. Anatomical differences in the mirror neuron system and social cognition network in autism. Cereb Cortex. 2006; 16(9): 1276–82
396
Cheng Y, Yang CY, Lin CP, Lee PL, Decety J. The perception of pain in others suppresses somatosensory oscillations: a magnetoencephalography study. Neuroimage. 2008; 40(4): 1833–40
397
Lamm C, Batson CD, Decety J. The neural substrate of human empathy: effects of perspective-taking and cognitive appraisal. J Cogn Neurosci. 2007; 19(1): 42–58
398
Botvinick M, Jha AP, Bylsma LM, Fabian SA, Solomon PE, Prkachin KM. Viewing facial expressions of pain engages cortical areas involved in the direct experience of pain. Neuroimage. 2005; 25(1): 312–9
399
Jabbi M, Swart M, Keysers C. Empathy for positive and negative emotions in the gustatory cortex. Neuroimage. 2007; 34(4): 1744–53
400
Hamilton AF. Goals, intentions and mental states: challenges for theories of autism. J Child Psychol Psychiatry. 2009; 50(8): 881–92
401
Dinstein I, Thomas C, Humphreys K, Minshew N, Behrmann M, Heeger DJ. Normal movement-selectivity in autism. Neuron. 2010; 66(3): 461–469. doi: 10.1016/j.neuron.2010.03.034
402
Ramachandran VS, Oberman LM. Broken mirrors: a theory of autism. Sci Am. 2006; 295(5): 62–9.
403
Baron-Cohen S, Leslie AM, Frith U. Does the autistic child have a «theory of mind»?. Cognition. 1985; 21(1): 37–46.
404
Ruffman T, Garnham W, Rideout P. Social understanding in autism: eye gaze as a measure of core insights. J Child Psychol Psychiatry. 2001; 42(8): 1083–94.
405
RETRACTED: Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351(9103):637–41
406
Fraser M., Anti-MMR doctor is forced out, The Telegraph, 02 Dec 2001.
407
Uhlmann V, Martin CM, Sheils O, et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. MP, Mol Pathol. 2002; 55(2): 84–90.
408
Goldacre M., The MMR hoax, The Guardian, 30 August 2008.
409
Health and Social Care Information Centre, NHS Immunisation Statistics England 2012–13, 26 September 2013
410
Deer B., MMR doctor Andrew Wakefield fixed data on autism, The Sunday Times, 8 February 2009
411
Horton R. The lessons of MMR. Lancet. 2004; 363 (9411): 747–9
412
Miriam Falco, Vaccine study's author held related patent, medical journal reports, CNN, January 12, 2011
413
RETRACTED: Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998; 351(9103): 637–41
414
Flaherty DK. The vaccine-autism connection: a public health crisis caused by unethical medical practices and fraudulent science. Ann Pharmacother. 2011; 45(10): 1302–4
415
Health and Social Care Information Centre, NHS Immunisation Statistics England 2012–13, 26, September 2013.
416
Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014; 32(29): 3623–9.
417
Seida JK, Ospina MB, Karkhaneh M, Hartling L, Smith V, Clark B. Systematic reviews of psychosocial interventions for autism: an umbrella review. Dev Med Child Neurol. 2009; 51(2): 95–104
418
Eikeseth S. Outcome of comprehensive psycho-educational interventions for young children with autism. Res Dev Disabil. 2009; 30(1): 158–78.
419
https://pubmed.ncbi.nlm.nih.gov/28110691.
420
https://pubmed.ncbi.nlm.nih.gov/26503762/.
421
https://molecularautism.biomedcentral.com/articles/10.1186/s13229–020–0313–1.
422
Buitelaar JK. Why have drug treatments been so disappointing?. Novartis Found Symp. 2003; 251: 235–44
423
Nicholas Lofthouse, Robert Hendren, Elizabeth Hurt, L. Eugene Arnold, and Eric Butter, «A Review of Complementary and Alternative Treatments for Autism Spectrum Disorders,» Autism Research and Treatment, vol. 2012, 2012
424
Tonya N. Davis et al., «Chelation Treatment for Autism Spectrum Disorders: A Systematic Review,» Research in Autism Spectrum Disorders 7 (January 2013): 49–55
425
Tonya N. Davis et al., «Chelation Treatment for Autism Spectrum Disorders: A Systematic Review,» Research in Autism Spectrum Disorders 7 (January 2013): 49–55
426
Myles, B. S., Huggins, A., Rome-Lake, M., Hagiwara, T., Barnhill, G. P., & Griswold, D. E. (2003). Written Language Profile of Children and Youth with Asperger Syndrome: From Research to Practice. Education and Training in Developmental Disabilities, 38(4), 362–369
427
Blume H., Autistics, freed from face-to-face encounters, are communicating in cyberspace. The New York Times, June 30, 1997
428
Saner E., 'It is not a disease, it is a way of life', The Guardian, 7 August 2007
429
https://www.autismspeaks.org/liub.
430
General Assembly resolution 62/139, World Autism Awareness Day, A/RES/62/139 (21 January 2008), available from undocs.org/A/RES/62/139.
431
Morel BA. Traité des maladies mentales. [Treatise on mental diseases]. Paris, France: Masson; 1860
432
Berrios GE. Phthisical insanity by T. S. Clouston. Hist Psychiatry. 2005; 16(Pt 4 (no 64)): 473–9
433
Hecker E. Die Hebephrenie: ein Beitrag zur klinischen Psychiatrie. [Hebephrenia: a contribution to clinical psychiatry] Archiv für pathologische Anatomie und für klinische Medizin. 1871
434
Kahlbaum KL. Die Gruppierung der psychischen Krankheiten und die Einteilung der Seelenstörungen. [The Grouping of Psychiatric Diseases and the Classification of Mental Disturbances]. Danzig, Germany: Kafemann; 1863
435
Kraepelin E. Psychiatrie. 6 Auflage. Leipzig, Austria: Barth 1899. English translation by Metoui H, Ayed S: Psychiatry, A Textbook for Students and Physicians
436
Waters FA, Badcock JC, Dragovic´ M, Jablensky A. Neuropsychological functioning in schizophrenia patients with first-rank (passivity) symptoms. Psychopathology. 2009; 42(1): 47–58
437
Wilkinson G. Political dissent and «sluggish» schizophrenia in the Soviet Union. British Medical Journal (Clinical research ed). 1986; 293(6548): 641–642
438
Bonnie RJ. Political abuse of psychiatry in the Soviet Union and in China: complexities and controversies. J Am Acad Psychiatry Law. 2002; 30(1): 136–44
439
World Health Organization. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization
440
Liddle PF. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry. 1987; 151: 145–51
441
Johnstone EC, Frith CD. Validation of three dimensions of schizophrenic symptoms in a large unselected sample of patients. Psychol Med. 1996; 26(4): 669–79
442
Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P. A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Arch Gen Psychiatry. 1995; 52(5): 352–60
443
World Health Organization. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization
444
F. Waters, C. Fernyhough. Hallucinations: A Systematic Review of Points of Similarity and Difference Across Diagnostic Classes. Schizophrenia Bulletin, Volume 43, Issue 1, 1 January 2017, Pages 32–43.
445
Lindström, E et al., The ICD-10 and DSM — IV diagnostic criteria and the prevalence of schizophrenia, European Psychiatry, (1997). Volume 12, Issue 5, 217–223
446
Upthegrove R, Birchwood M, Ross K, Brunett K, Mccollum R, Jones L. The evolution of depression and suicidality in first episode psychosis. Acta Psychiatr Scand. 2010; 122(3): 211–8
447
Sham PC, Maclean CJ, Kendler KS. A typological model of schizophrenia based on age at onset, sex and familial morbidity. Acta Psychiatr Scand. 1994; 89(2): 135–41
448
Brugha T, Singleton N, Meltzer H, et al. Psychosis in the community and in prisons: a report from the British National Survey of psychiatric morbidity. Am J Psychiatry. 2005; 162(4): 774–80
449
Ostling S, Skoog I. Psychotic symptoms and paranoid ideation in a nondemented population-based sample of the very old. Arch Gen Psychiatry. 2002; 59(1): 53–9
450
Лаувенг А. Завтра я всегда бывала львом. — М.: Бахрах-М, 2012
451
Trémeau F, Antonius D, Cacioppo JT, et al. In support of Bleuler: objective evidence for increased affective ambivalence in schizophrenia based upon evocative testing. Schizophr Res. 2009; 107(2–3): 223–31
452
De Clerambault, Psychoses a base d'automatisme (1925), La Psychiatrie, 1994: 511
453
Kiran C, Chaudhury S. Understanding delusions. Industrial Psychiatry Journal. 2009; 18(1): 3–18
454
О'Брайен Б. Необыкновенное путешествие в безумие и обратно: Операторы и вещи. — М.: Класс, 1996
455
Steven M. Silverstein, Adriann Lai: The Phenomenology and Neurobiology of Visual Distortions and Hallucinations in Schizophrenia: An Update. Front. Psychiatry, 11 June 2021.
456
Byrne P. Managing the acute psychotic episode. BMJ: British Medical Journal. 2007; 334(7595): 686–692
457
Van rensburg AB, Olorunju S. Diagnosis and treatment of schizophrenia in a general hospital based acute psychiatric ward. Afr J Psychiatry (Johannesbg). 2010; 13(3): 204–10
458
Surviving Schizophrenia: A Manual for Families, Patients, and Providers (5th Edition) by E. Fuller Torrey (Author), Publisher: Quill; 5th edition (April 1, 2006).
459
Mitchison A., Kim Noble: The woman with 100 personalities, The Guardian, 30 September 2011
460
Nathan PE, Gorman JM. A Guide to Treatments that Work. Oxford University Press, USA; 2007: 463–5
461
Beidel DC, Frueh BC, Hersen M. Adult Psychopathology and Diagnosis. John Wiley & Sons; 2014.
462
Korol S. Familial and social support as protective factors against the development of dissociative identity disorder. J Trauma Dissociation. 2008; 9(2): 249–67
463
Gillig PM. Dissociative identity disorder: a controversial diagnosis. Psychiatry (Edgmont). 2009; 6(3): 24–9.
464
Galvin JE, Sadowsky CH. Practical guidelines for the recognition and diagnosis of dementia. J Am Board Fam Med. 2012; 25(3): 367–82
465
Burns A, Iliffe S. Dementia. BMJ. 2009; 338: b75
466
Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007; 6(11): 994–1003
467
O'donovan MC, Williams NM, Owen MJ. Recent advances in the genetics of schizophrenia. Hum Mol Genet. 2003; 12 Spec № 2: R125–33
468
Torrey EF. Surviving Schizophrenia, 6th Edition, A Family Manual. Harper Perennial; 2013: 135
469
Van os J, Kapur S. Schizophrenia. Lancet. 2009; 374(9690): 635–45
470
Cardno AG, Marshall EJ, Coid B, et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry. 1999; 56(2): 162–8
471
Kendler KS, Mcguire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch Gen Psychiatry. 1993; 50(7): 527–40
472
O'Donovan MC, Williams NM, Owen MJ. Recent advances in the genetics of schizophrenia. Hum Mol Genet. 2003; 12 Spec № 2: R125–33
473
Torrey EF, Yolken RH. Psychiatric Genocide: Nazi Attempts to Eradicate Schizophrenia. Schizophrenia Bulletin. 2010; 36(1): 26–32
474
Crow TJ. Schizophrenia as the price that homo sapiens pays for language: a resolution of the central paradox in the origin of the species. Brain Res Brain Res Rev. 2000; 31(2–3): 118–29
475
Burns JK. An evolutionary theory of schizophrenia: cortical connectivity, metarepresentation, and the social brain. Behav Brain Sci. 2004; 27(6): 831–55
476
Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III — the final common pathway. Schizophr Bull. 2009; 35(3): 549–62
477
Carlsson A., Carlsson ML. Dopaminergic stabilisers. Adv Schizophrenia and Clin Psychiatry. 2005; 1: 118–128
478
Da silva alves F, Figee M, Van amelsvoort T, Veltman D, De haan L. The revised dopamine hypothesis of schizophrenia: evidence from pharmacological MRI studies with atypical antipsychotic medication. Psychopharmacol Bull. 2008; 41(1): 121–32
479
Pogarell O, Koch W, Karch S, et al. Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptoms. Pharmacopsychiatry, 2012; 45 Suppl 1: S36–41
480
Mechri A, Saoud M, Khiari G, D'amato T, Dalery J, Gaha L. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine]. Encephale. 2001; 27(1): 53–9
481
Reynolds LM, Cochran SM, Morris BJ, Pratt JA, Reynolds GP. Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain. Schizophr Res. 2005; 73(2–3): 147–52
482
Coyle JT. NMDA receptor and schizophrenia: a brief history. Schizophr Bull. 2012; 38(5): 920–6
483
Upthegrove, R., & Khandaker, G. M. (2020). Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia. Current topics in behavioral neurosciences, 44, 49–66. https://doi.org/10.1007/7854_2018_88.
484
Richard A, Churan J, Whitford V, O'driscoll GA, Titone D, Pack CC. Perisaccadic perception of visual space in people with schizophrenia. J Neurosci. 2014; 34(14):4760–5
485
Bateson, G., Jackson, D. D., Haley, J. & Weakland, J. (1956), Towards a Theory of Schizophrenia. in Behavioral Science, Vol 1, 251–264
486
Large M, Smith G, Nielssen O. The relationship between the rate of homicide by those with schizophrenia and the overall homicide rate: a systematic review and meta-analysis. Schizophr Res. 2009; 112(1–3):123–9
487
Phelan, J. C., Link, B. G., Stueve, A., & Pescosolido, B. A. (2000). Public Conceptions of Mental Illness in 1950 and 1996: What Is Mental Illness and Is It to be Feared? Journal of Health and Social Behavior, 41(2), 188–207
488
Pronin, E., Perception and misperception of bias in human judgment, (2007) Trends in Cognitive Sciences, Volume 11, Issue 1, 37–43
489
Walsh E, Fahy T. Violence in society: Contribution of mental illness is low. BMJ: British Medical Journal. 2002; 325(7363): 507–508
490
Burton N. The Meaning of Madness. Oxford: Acheron Press, 2009; 2008
491
Kaufman SB, How Is Creativity Differentially Related to Schizophrenia and Autism? Scientific American, June 10, 2015
492
Marquis DM. In Search of Buddy Bolden, First Man of Jazz. LSU Press; 2005
493
Jobe TH, Harrow M. Long-term outcome of patients with schizophrenia: a review. Can J Psychiatry. 2005; 50(14): 892–900
494
Harrison G, Hopper K, Craig T, et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry. 2001; 178: 506–17
495
Saks ER., Diary of a High-Functioning Person with Schizophrenia, Scientific American, December 29, 2009
496
Под таким названием перевод книги можно найти в рунете.
497
Wiersma D, Wanderling J, Dragomirecka E, et al. Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol Med. 2000; 30 (5): 1155–67
498
Ruhrmann S, Schultze-lutter F, Salokangas RK, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry. 2010; 67(3): 241–51
499
Doroshow DB. Performing a cure for schizophrenia: insulin coma therapy on the wards. J Hist Med Allied Sci. 2007;62 (2):213–43
500
Raz M. The painless brain: lobotomy, psychiatry, and the treatment of chronic pain and terminal illness. Perspect Biol Med. 2009; 52(4): 555–65
501
Epstein NN. Artificial Fever as a Therapeutic Procedure. Cal West Med. 1936; 44(5): 357–8
502
«The Nobel Prize in Physiology or Medicine 1927». Nobelprize.org. Nobel Media AB2014. Web. 14 Mar 2016. http://www.nobelprize.org/nobel_prizes/medicine/laureates/1927/
503
Hamon, Paraire, Velluz. [Effect of R. P. 4560 on maniacal agitation]. Ann Med Psychol (Paris). 1952; 110: 331–5
504
Ban TA. Fifty years chlorpromazine: a historical perspective. Neuropsychiatric Disease and Treatment. 2007; 3(4): 495–500
505
Ban TA. Pharmacotherapy of mental illness — a historical analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2001; 25(4): 709–27
506
Carlsson A, Carlsson ML. A dopaminergic deficit hypothesis of schizophrenia: the path to discovery. Dialogues in Clinical Neuroscience. 2006; 8(1):137–142
507
Muench J, Hamer AM. Adverse effects of antipsychotic medications. Am Fam Physician. 2010; 81(5): 617–22
508
Crilly J. The history of clozapine and its emergence in the US market: a review and analysis. Hist Psychiatry. 2007; 18(1): 39–60
509
Brisch R, Saniotis A, Wolf R, et al. The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue. Frontiers in Psychiatry. 2014; 5:47. doi: 10.3389/fpsyt.2014.00047
510
Xiberas X, Martinot JL, Mallet L, et al. Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia. Br J Psychiatry. 2001; 179: 503–8
511
Correll, C. U., Davis, R. E., Weingart, M., Saillard, J., O'Gorman, C., Kane, J. M., Lieberman, J. A., Tamminga, C. A., Mates, S., & Vanover, K. E. (2020). Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial. JAMA psychiatry, 77(4), 349–358.
512
D'Souza, I., Durgam, S., Satlin, A., Davis, R. E., Kozauer, S. G., Chen, R., Mates, S., & Calabrese, J. R. (2021). Lumateperone (ITI-007) in the Treatment of Bipolar Depression: Results from a Randomized Clinical Trial. CNS spectrums, 26(2), 150.
513
Хаэр Р. Лишенные совести: Пугающий мир психопатов. — М.: Вильямс, 2014.
514
World Health Organization. The ICD-1 °Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization, 1992
515
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (Fifth ed.). Arlington, VA: American Psychiatric Publishing
516
Ющенко А. И. Основы учений о преступнике, душевнобольном и психологии нормального человека. Введение в курс судебной психопатологии. — СПб.: Издание К. Л. Риккера, 1913.
517
Каннабих Ю. В. История психиатрии. — Л.: Государственное медицинское издательство, 1928
518
Буянин Д. Диспут о Канте закончился стрельбой в Ростове // РИА «Новости». 2013. 16 сентября
519
Bürgy M. The Concept of Psychosis: Historical and Phenomenological Aspects. Schizophrenia Bulletin. 2008; 34(6):1200–1210
520
Ferrero J. Lombroso's Criminal Man. N.Y., 1919. P. XIV
521
Goring C. The English Convict. L., 1913. P. 173
522
Cleckley, Hervey (1982). The Mask of Sanity. Revised Edition. Mosby Medical Library.
523
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 3rd edition. Washington, DC American Psychiatric Association; 1980
524
Hare, R. D. (1980). A research scale for the assessment of psychopathy in criminal populations. Personality and Individual Differences, 1, 111–117
525
Хаэр Р. Лишенные совести: Пугающий мир психопатов. — М.: Вильямс, 2014.
526
Moran P. The epidemiology of antisocial personality disorder. Soc Psychiatry Psychiatr Epidemiol. 1999; 34(5): 231–42
527
Хаэр Р. Лишенные совести: Пугающий мир психопатов. — М.: Вильямс, 2014
528
Antisocial Personality Disorder: Treatment, Management and Prevention. NICE Clinical Guidelines, No. 77. National Collaborating Centre for Mental Health (UK).Leicester (UK): British Psychological Society; 2010
529
Lilienfeld SO. Doctoral Dissertation. University of Minnesota; Minneapolis: 1990. Development and preliminary validation of a slf-report of psychopathic personality
530
McWilliams N. Psychoanalytic Diagnosis, Understanding Personality Structure in the Clinical Process. Guilford Press; 1994
531
Даттон К. Мудрость психопатов. — СПб.: Питер, 2014.
532
Kent A. Kiehl, Peter F. Liddle, Andra M. Smith, Adrianna Mendrek, Bruce B. Forster and Robert D. Hare. Neural pathways involved in the processing of concrete and abstract words. Psychophysiology, 36 (1999).
533
Thomas ST, Sociopaths Confirm: They're Great in Bed (But They Might Treat You Like a Houseplant), Vice, July 19, 2015
534
http://www.sociopathworld.com/
535
Dutton DL. The cold reading technique. Experientia. 1988; 44(4): 326–32.
536
Wheeler S, Book A, Costello K. Psychopathic Traits and Perceptions of Victim Vulnerability, Criminal Justice and Behavior Volume:36 Issue:6, June 2009: 635–48
537
Cleckley HM. The Mask of Sanity. Textbook Pub; 2003
538
Eysenck EJ, Personality and the Biosocial Model of Anti-Social and Criminal Behaviour, Biosocial Bases of Violence, Springer US, 1997: 21–37
539
Quay, Herbert C. 1965. Psychopathic personality as pathological stimulation seeking. American Journal of Psychiatry, 122, 180–183
540
Raine A, Fung AL, Portnoy J, Choy O, Spring VL. Low heart rate as a risk factor for child and adolescent proactive aggressive and impulsive psychopathic behavior. Aggress Behav. 2014; 40(4): 290–9
541
Raine A, Venables PH, Mednick SA. Low resting heart rate at age 3 years predisposes to aggression at age 11 years: evidence from the Mauritius Child Health Project. J Am Acad Child Adolesc Psychiatry. 1997; 36(10): 1457–64.
542
Ortiz J, Raine A. Heart rate level and antisocial behavior in children and adolescents: a meta-analysis. J Am Acad Child Adolesc Psychiatry. 2004; 43(2): 154–62
543
From Craig, M., Catani, M., Deeley, Q., Latham, R., Daly, E., Kanaan, R., Picchioni, M., McGuire, P., Fahy, T., & Murphy, D. (2009). Altered connections on the road to psychopathy Molecular Psychiatry, 14 (10), 946–953 DOI: 10.1038/mp.2009.40
544
Koenigs M, Kruepke M, Newman JP. Economic decision-making in psychopathy: a comparison with ventromedial prefrontal lesion patients. Neuropsychologia. 2010; 48(7): 2198–204
545
McWilliams N. Psychoanalytic Diagnosis, Understanding Personality Structure in the Clinical Process. Guilford Press; 1994
546
Rothemund Y, Ziegler S, Hermann C, et al. Fear conditioning in psychopaths: event-related potentials and peripheral measures. Biol Psychol. 2012; 90(1): 50–9
547
Birbaumer N, Veit R, Lotze M, et al. Deficient fear conditioning in psychopathy: a functional magnetic resonance imaging study. Arch Gen Psychiatry. 2005; 62(7): 799–805
548
Hare RD. Detection threshold for electric shock in psychopaths. J Abnorm Psychol. 1968; 73(3): 268–72
549
Blair, R. J. R. (2010). Psychopathy, frustration, and the role of reactive aggression: The role of the ventromedial prefrontal cortex. British Journal of Psychology, 101, 383–399
550
Buckholtz JW, Treadway MT, Cowan RL, et al. Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Nat Neurosci. 2010; 13(4): 419–21
551
Konnikova M, Stop Calling Sherlock a Sociopath! Thanks, a Psychologist, Criminal Element, Aug 8 2012, Available at: http://www.criminalelement.com/blogs/2012/08/stop-calling-sherlock-a-sociopath-psychologist-maria-konnikova. Accessed March 16, 2016
552
Craig, M., Catani, M., Deeley, Q., Latham, R., Daly, E., Kanaan, R., Picchioni, M., McGuire, P., Fahy, T., & Murphy, D. (2009). Altered connections on the road to psychopathy Molecular Psychiatry, 14 (10)
553
Kevin M. Beavera, Matt DeLisib, Michael G. Vaughnc, J. C. Barnesa. Monoamine oxidase A genotype is associated with gang membership and weapon use
554
Caspi A et al, Role of Genotype in the Cycle of Violence in Maltreated Children, Science, 2002 (5582/297): 851–4
555
Khalifa N, Duggan C, Stoffers J, et al. Pharmacological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2010; (8): CD007667
556
Harris Grant T, et al. Psychopathy and Violent Recidivism. Law & Hum Behav. 1991; 15: 625.
557
http://www.worldsciencefestival.com/2011/09/moth_confessions_of_a_pro_social_psychopath/
558
Morton RJ, Serial Murder: Multi-Disciplinary Perspectives for Investigators, National Ctr for the Analysis of Violent Crime (NCAVC), 2008
559
Hasler G, Hopwood CJ, Jacob GA, Brändle LS, Schulte-vels T. Patient-reported outcomes in borderline personality disorder. Dialogues Clin Neurosci. 2014; 16(2): 255–66
560
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author: 663–6
561
Cohen P. Child development and personality disorder. Psychiatr Clin North Am. 2008; 31(3): 477–93, vii.
562
Zanarini MC, Frankenburg FR, Reich DB, et al. Biparental failure in the childhood experiences of borderline patients. J Pers Disord. 2000; 14(3): 264–73
563
Zanarini MC, Frankenburg FR. Pathways to the development of borderline personality disorder. J Pers Disord. 1997; 11(1): 93–104
564
Goldman SJ, D'angelo EJ, Demaso DR. Psychopathology in the families of children and adolescents with borderline personality disorder. Am J Psychiatry. 1993; 150(12): 1832–5
565
South SC, Turkheimer E, Oltmanns TF. Personality disorder symptoms and marital functioning. J Consult Clin Psychol. 2008; 76(5): 769–80
566
Bui E, Rodgers R, Chabrol H, Birmes P, Schmitt L. Is Anakin Skywalker suffering from borderline personality disorder? Psychiatry Res. 2011; 185(1–2): 299
567
Kreger R, Putting Darth Vader On The Couch, Psychology Today, Jun 2010
568
Coid J, Yang M, Tyrer P, Roberts A, Ullrich S. Prevalence and correlates of personality disorder in Great Britain. Br J Psychiatry. 2006; 188: 423–31
569
Samuels J, Eaton WW, Bienvenu OJ, Brown CH, Costa PT, Nestadt G. Prevalence and correlates of personality disorders in a community sample. Br J Psychiatry. 2002; 180: 536–42
570
Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 2001; 58(6): 590–6
571
Grant BF, Chou SP, Goldstein RB, et al. Prevalence, correlates, disability, and comorbidity of DSM — IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008; 69(4): 533–45
572
Skodol AE, Gunderson JG, Mcglashan TH, et al. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Am J Psychiatry. 2002; 159(2): 276–83
573
Oumaya M, Friedman S, Pham A, Abou abdallah T, Guelfi JD, Rouillon F. [Borderline personality disorder, self-mutilation and suicide: literature review]. Encephale. 2008; 34(5): 452–8
574
Torgersen S, Lygren S, Oien PA, et al. A twin study of personality disorders. Compr Psychiatry. 2000; 41(6): 416–25
575
Reichborn-kjennerud T, Czajkowski N, Neale MC, et al. Genetic and environmental influences on dimensional representations of DSM — IV cluster C personality disorders: a population-based multivariate twin study. Psychol Med. 2007; 37(5): 645–53
576
Gratz AC. The Borderline Personality Disorder: Everything You Need to Know about Living with Bpd (Large Print 16pt). ReadHowYouWant.com; 2010
577
Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996; 274(5292): 1527–31
578
Rinne T, Westenberg HG, Den boer JA, Van den brink W. Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients. Biol Psychiatry. 2000; 47(6): 548–56
579
Herpertz SC, Dietrich TM, Wenning B, et al. Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study. Biol Psychiatry. 2001; 50(4): 292–8
580
Gunderson JG, Sabo AN. The phenomenological and conceptual interface between borderline personality disorder and PTSD. Am J Psychiatry. 1993; 150(1): 19–27
581
Twenge JM, Gentile B, Dewall CN, Ma D, Lacefield K, Schurtz DR. Birth cohort increases in psychopathology among young Americans, 1938–2007: A cross-temporal meta-analysis of the MMPI. Clin Psychol Rev. 2010; 30(2): 145–54
582
Tebartz van elst L, Hesslinger B, Thiel T, et al. Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study. Biol Psychiatry. 2003; 54(2): 163–71
583
Rausch J, Gäbel A, Nagy K, Kleindienst N, Herpertz SC, Bertsch K. Increased testosterone levels and cortisol awakening responses in patients with borderline personality disorder: gender and trait aggressiveness matter. Psychoneuroendocrinology. 2015; 55: 116–27
584
Miller PM, Lisak D, Associations Between Childhood Abuse and Personality Disorder Symptoms in College Males J Interpers Violence June 1999, 14: 642–656
585
Cohen P. Child development and personality disorder. Psychiatr Clin North Am. 2008; 31(3): 477–93, vii.
586
Zanarini MC, Frankenburg FR, Reich DB, et al. Biparental failure in the childhood experiences of borderline patients. J Pers Disord. 2000; 14(3): 264–73
587
Waters E, Merrick S, Treboux D, Crowell J, Albersheim L. Attachment security in infancy and early adulthood: a twenty-year longitudinal study. Child Dev. 2000; 71(3): 684–9
588
https://link.springer.com/chapter/10.1007/978–3–030–49414–8_12.
589
https://pubmed.ncbi.nlm.nih.gov/11154711/
590
https://pubmed.ncbi.nlm.nih.gov/18729605/
591
https://pubmed.ncbi.nlm.nih.gov/14712172/
592
https://pubmed.ncbi.nlm.nih.gov/10401504/
593
Lenzenweger MF, Lane MC, Loranger AW, Kessler RC. DSM — IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007; 62(6): 553–64
594
Zanarini MC, Frankenburg FR, Hennen J, Silk KR. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. Am J Psychiatry. 2003; 160(2): 274–83
595
Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev. 2007; 27(8): 959–85
596
Kane JM, Jeste DV, Barnes TR: Tardive dyskinesia: A task force report of the American Psychiatric Association. Washington, D.C: American Psychiatric Association; 1992. Ref Type: Report
597
Ebert A, Kolb M, Heller J, Edel MA, Roser P, Brüne M. Modulation of interpersonal trust in borderline personality disorder by intranasal oxytocin and childhood trauma. Soc Neurosci. 2013; 8(4): 305–13
598
Bertsch K, Gamer M, Schmidt B, et al. Oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder. Am J Psychiatry. 2013; 170(10): 1169–77
599
Amad A, Thomas P, Perez-rodriguez MM. Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future Directions. Curr Pharm Des. 2015; 21(23): 3311–6
600
Bateman A, Fonagy P. Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. Am J Psychiatry. 2001; 158(1): 36–42
601
Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry. 2009; 166(12): 1355–64
602
Choi-Kain LW, Albert EB, Gunderson JG: Evidence-based treatments for borderline personality disorder: implementation, integration, and stepped care. Harv Rev Psychiatry 2016.
603
Закон Российской Федерации от 2 июля 1992 г. № 3185 I (ред. от 21.11.2011 г.) «О психиатрической помощи и гарантиях прав граждан при ее оказании», ст. 27
604
605
https://rg.ru/2021/03/28/pochemu-v-rossii-uzhestochili-pravila-oborota-fenazepama.html.
606
Использование должностным лицом своих служебных полномочий для удовлетворения личных амбиций вопреки интересам службы. Термин был впервые использован Ф. М. Достоевским в романе «Бесы».
607
Не все герои упомянутых ниже художественных произведений имели официальные диагнозы, но их поведение, по мнению специалистов и/или больных психическими расстройствами, иллюстрирует особенности людей с тем или иным заболеванием.
ТЕЛЕГРАМКанал с обзорами, анонсами новинок и книжными подборками
Книжный Вестник
Бот для удобного поиска книг (если не нашлось на сайте)
Поиск книг
Свежие любовные романы в удобных форматах
Любовные романы
О психологии, саморазвитии и личностном росте
Саморазвитие
Детективы и триллеры, все новинки
Детективы
Фантастика и фэнтези, все новинки
Фантастика
Отборные классические книги
Классика
ВКОНТАКТЕБиблиотека с любовными романами, которая наверняка придётся по вкусу женской части аудитории
Любовные романы
Библиотека с фантастикой и фэнтези, а также смежных жанров
Фантастика
Самые популярные книги в формате фб2
Топ фб2
книги